Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Eltrombopag 25 mg price?Ultravist generic name?Flecainide patent expiration?Eltrombopag generico?Eltrombopag patent expiry date germany?
See the DrugPatentWatch profile for auryxia
Auryxia is used to treat adults with chronic kidney disease (CKD) who have elevated phosphorus levels. It works as a phosphate binder, helping lower blood phosphorus by binding dietary phosphate in the gastrointestinal tract so it is excreted instead of absorbed.
Auryxia is prescribed for: - Adults with CKD on dialysis (to control hyperphosphatemia) - Adults with CKD not on dialysis (also to control hyperphosphatemia)
Auryxia is specifically for managing high phosphorus in CKD. It is not used as a general treatment for anemia, infections, or other causes of kidney-related symptoms unless those are part of a broader CKD care plan.
Auryxia is taken by mouth with meals (or as directed by a clinician) because phosphate from food is the target it binds in the gut.
Other Questions About Auryxia :